Chong-Hui Gu

Chong-Hui Gu is currently the VP, CMC & QA at Foghorn Therapeutics. Chong-Hui has over 15 years of experience in the pharmaceutical industry. Prior to joining Foghorn, they were a research fellow at Vertex Pharmaceuticals from July 2006 to October 2012. Before that, they were a senior research investigator at Bristol-Myers Squibb from January 2001 to January 2006.

Chong-Hui Gu received their PhD in medicinal chemistry from the University of Kansas in 2001. Chong-Hui also completed postdoctoral training in chemical biology at Harvard Medical School.

Chong-Hui Gu graduated from the University of Minnesota with a degree in education.

Chong-Hui Gu reports to Adrian Gottschalk, President & CEO. Some of their coworkers include Allan Reine - Chief Financial Officer, Scott Innis - VP, Program Leadership, and Murphy Hentemann - VP, Program Leadership.